NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Balk EM, Adam GP, Langberg V, et al. Omega-3 Fatty Acids and Cardiovascular Disease: An Updated Systematic Review. Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Aug. (Evidence Reports/Technology Assessments, No. 223.)
This publication is provided for historical reference only and the information may be out of date.
The Agency for Healthcare Research and Quality (AHRQ), through its Evidence-based Practice Centers (EPCs), sponsors the development of systematic reviews to assist public- and private-sector organizations in their efforts to improve the quality of health care in the United States. These reviews provide comprehensive, science-based information on common, costly medical conditions, and new health care technologies and strategies.
Systematic reviews are the building blocks underlying evidence-based practice; they focus attention on the strength and limits of evidence from research studies about the effectiveness and safety of a clinical intervention. In the context of developing recommendations for practice, systematic reviews can help clarify whether assertions about the value of the intervention are based on strong evidence from clinical studies. For more information about AHRQ EPC systematic reviews, see www.effectivehealthcare.ahrq.gov/reference/purpose.cfm.
AHRQ expects that these systematic reviews will be helpful to health plans, providers, purchasers, government programs, and the health care system as a whole. Transparency and stakeholder input are essential to the Effective Health Care Program. Please visit the Web site (www.effectivehealthcare.ahrq.gov) to see draft research questions and reports or to join an email list to learn about new program products and opportunities for input.
If you have comments on this systematic review, they may be sent by mail to the Task Order Officer named below at: Agency for Healthcare Research and Quality, 5600 Fishers Lane, Rockville, MD 20857, or by email to vog.shh.qrha@cpe.
- Andrew Bindman, M.D.DirectorAgency for Healthcare Research and Quality
- Stephanie Chang, M.D., M.P.H.DirectorEvidence-based Practice Center ProgramCenter for Evidence and Practice ImprovementAgency for Healthcare Research and Quality
- Arlene S. Bierman, M.D., M.S.DirectorCenter for Evidence and Practice ImprovementAgency for Healthcare Research and Quality
- Aysegul Gozu, M.D., M.P.H.Task Order OfficerCenter for Evidence and Practice ImprovementAgency for Healthcare Research and Quality
- Preface - Omega-3 Fatty Acids and Cardiovascular DiseasePreface - Omega-3 Fatty Acids and Cardiovascular Disease
- Peer Reviewers - Omega-3 Fatty Acids and Cardiovascular DiseasePeer Reviewers - Omega-3 Fatty Acids and Cardiovascular Disease
- Reinekea blandensis MED297Reinekea blandensis MED297This strain was collected in the NW Mediterranean Sea.BioProject
- Mus musculus estrogen-induced osteoclastogenesis regulator 1 (Eeig1), mRNAMus musculus estrogen-induced osteoclastogenesis regulator 1 (Eeig1), mRNAgi|2176733615|ref|NM_153560.5|Nucleotide
- Homo sapiens leucine zipper like post translational regulator 1 (LZTR1), RefSeqG...Homo sapiens leucine zipper like post translational regulator 1 (LZTR1), RefSeqGene (LRG_989) on chromosome 22gi|663071208|ref|NG_034193.1||gnl|L G_989Nucleotide
Your browsing activity is empty.
Activity recording is turned off.
See more...